Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Neogen stock

NEOG
US6404911066
883297

Price

14.20
Today +/-
+0.03
Today %
+0.24 %

Neogen stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Neogen stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Neogen stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Neogen stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Neogen's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Neogen Stock Price History

DateNeogen Price
11/26/202414.20 undefined
11/26/202414.17 undefined
11/25/202415.31 undefined
11/22/202414.98 undefined
11/21/202414.58 undefined
11/20/202414.90 undefined
11/19/202415.09 undefined
11/18/202415.20 undefined
11/15/202414.60 undefined
11/14/202414.64 undefined
11/13/202415.04 undefined
11/12/202415.34 undefined
11/11/202416.40 undefined
11/8/202416.23 undefined
11/7/202415.78 undefined
11/6/202415.62 undefined
11/5/202415.02 undefined
11/4/202414.43 undefined
11/1/202414.44 undefined
10/31/202414.28 undefined
10/30/202414.57 undefined
10/29/202414.34 undefined

Neogen Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Neogen, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Neogen from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Neogen’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Neogen. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Neogen’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Neogen’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Neogen’s growth potential.

Neogen Revenue, EBIT and net profit per share

DateNeogen RevenueNeogen EBITNeogen Net Income
2027e1.05 B undefined156.64 M undefined162.46 M undefined
2026e1 B undefined111.12 M undefined131.52 M undefined
2025e955.44 M undefined81.59 M undefined103.89 M undefined
2024924.22 M undefined74.18 M undefined-9.42 M undefined
2023822.4 M undefined97.3 M undefined-22.9 M undefined
2022527.2 M undefined58.6 M undefined48.3 M undefined
2021468.5 M undefined74.2 M undefined60.9 M undefined
2020418.2 M undefined67.5 M undefined59.5 M undefined
2019414.2 M undefined68.1 M undefined60.2 M undefined
2018397.9 M undefined70.2 M undefined63.1 M undefined
2017358.3 M undefined64.9 M undefined43.8 M undefined
2016321.3 M undefined56.4 M undefined36.6 M undefined
2015283.1 M undefined53.1 M undefined33.5 M undefined
2014247.4 M undefined43.4 M undefined28.2 M undefined
2013207.5 M undefined40.7 M undefined27.2 M undefined
2012184 M undefined33.7 M undefined22.5 M undefined
2011172.7 M undefined35.8 M undefined22.8 M undefined
2010140.5 M undefined26.9 M undefined17.5 M undefined
2009118.7 M undefined20.5 M undefined13.9 M undefined
2008102.4 M undefined18 M undefined12.1 M undefined
200786.1 M undefined13.5 M undefined9.1 M undefined
200672.4 M undefined10.8 M undefined7 M undefined
200562.8 M undefined7.5 M undefined4.9 M undefined

Neogen Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
1992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
0.010.010.010.010.010.020.020.020.020.030.040.050.060.060.070.090.10.120.140.170.180.210.250.280.320.360.40.410.420.470.530.820.920.9611.05
-16.6742.8610.009.0925.0020.0022.224.5547.8323.5311.9017.0212.7316.1319.4418.6015.6918.6422.866.9812.5019.3214.5713.4311.5310.894.280.9711.9612.6155.9812.413.354.924.89
33.3342.8660.0054.5558.3360.0055.5654.5552.1750.0050.0053.1949.0948.3951.3951.1651.9650.0052.1450.5850.0052.6649.3949.1247.6646.9346.8546.1446.8945.9446.1149.3950.1148.4846.2144.05
236679101212172125273037445359738792109122139153168186191196215243406463000
0000012233345479121317222227283336436360596048-22-9103131162
------100.00-50.00--33.3325.00-20.0075.0028.5733.338.3330.7729.41-22.733.7017.869.0919.4446.51-4.76-1.671.69-20.00-145.83-59.09-1,244.4427.1823.66
43.745.550.952.650.863.57269.166.666.671.771.975.475.276.1859090.392.495.296.197.399.499.9101102.3104.3104.9105.7107.1108188.9216.48000
------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Neogen Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Neogen is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (k)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                 
2.81.732.22.21310.610.710.77.26.48.91.72213.414.313.822.856.168.685.476.5114.2107.8143.6210.8267.5343.7381.1381.1245.6170.94
11.11.21.71.623.13.34.966.57.59.910.513.114.919.423.427.428.635.738.751.959.267.768.679.182.684.791.899.7153.3173.01
000000000000000000000000000000000
2.32.52.43.83.43.64.54.45.478.79.812.413.817.619.127.831.431.3323538.351.251.664.473.1768695.1100.7122.3133.8189.27
0.20.20.30.40.30.40.410.71.42.11.72.32.23.63.74.23.24.55.74.66.19.26.28.47.69.913.41417.823.853.3112.05
6.35.56.98.17.51918.619.421.721.623.727.926.328.536.351.165.771.886122.4143.9168.5188.8231.2248.3292.9375.8449.5537.5591.4626.9586645.26
10.90.91.31.41.61.92.12.72.73.74.61112.214.316.416.917.119.222.329.934.341.944.554.761.773.174.880.6102.9113.8210.7291.89
000000000000000000000000000000000
000000000000000000000000000000000
0000000.010.010.01000000.010.010.010.010.020.020.020.030.050.050.060.070.070.070.070.090.111.611.51
000-0-0-0-0-0-00.010.010.010.020.020.030.020.030.040.050.050.050.060.070.070.090.10.10.10.110.130.142.142.14
0.20.40.500000000000000000000000002.222.215.220.43
0000000.010.010.010.010.020.020.030.040.050.050.060.070.090.10.110.120.160.160.20.240.240.250.260.330.373.973.96
0.010.010.010.010.010.020.030.030.030.030.040.050.060.060.090.110.130.140.180.220.250.290.350.390.450.530.620.70.80.920.994.554.6
                                                                 
0.60.70.70.70.7110.90.90.911.21.31.31.32.22.33.53.63.73.85.85.95.966.18.38.48.517.217.234.634.66
0.010.010.010.010.010.020.020.020.020.020.020.020.030.030.040.050.060.060.070.080.090.10.120.130.150.180.20.220.260.30.312.572.58
-6.5-7-6.1-5.5-5.7-3.9-1.70.63.76.810.815.620.726.628.537.649.763.681.2104.1126.7153.9182215.6252.1295.9359.1419.2478.7539.6587.9565555.62
000000000000100100100400400-400-1,700-400-1,200-1,400400-2,400-3,900-7,200-9,700-11,600-19,700-11,500-25,500-33,300-30,021
00000000000000000000000000000200-2,30000
0.010.010.010.010.010.020.020.020.030.030.040.040.050.050.070.090.110.130.150.190.220.260.310.350.40.470.560.640.730.840.893.133.14
0.50.50.70.70.50.80.60.81.71.22.33.33.12.32.84.56.53.97.28.510.89.213.413.715.816.220.819.125.723.934.676.783.06
0.30.30.60.40.50.90.810.711.42.12.636.34.24.34.779.38.48.311.610.512.818.817.818.621.427.935.657.253.73
00000.20000.410.20.300.30.91.40.30.72.800.80.201.300.90.20.61.51.87.611.615.08
0001.110000000000000000000000000000
0.40.30.10.10.10.1000.5000000000000000000000002.45
1.21.11.42.32.31.81.41.83.33.23.95.75.75.61010.111.19.31717.82017.72525.528.635.938.838.348.653.677.8145.5154.32
0.10.100.40.30.20.20.10.10003.90100000000000000000885.4888.39
00000000000.40.40.91.31.11.42.32.75.88.31012.412.213.714.81714.115.618.121.917353.4326.72
0000.10.10.20.20.30.30.30.40.51.721.81.91.61.54.34.52.62.11.92.12.43.6545.44.310.735.935.26
0000000000000.0100.010000.010.010.010.010.010.020.020.020.020.020.020.030.031.271.25
000000000000.010.010.010.020.010.020.010.030.030.030.030.040.040.050.060.060.060.070.080.111.421.4
0.010.010.010.010.010.020.030.030.030.030.040.050.060.060.090.110.130.140.180.220.250.290.350.390.450.530.620.70.80.920.994.554.55
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Neogen provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Neogen's financial health and stability.

Assets

Neogen's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Neogen must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Neogen after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Neogen's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0000012233345479121317222227283336436360596048-22
00000000011111223345679101214171718212388
00000000000000000102100010-3110-4-19
000-100-100-1-10-4-10-3-9-940-8-8-13-2-180-13-200-6-6-26
0000000000000101133133267691112121431
000000000000000000000000000000042
0000000001212213776968910131311137141715
0010021342362611107102728222621433560696385816841
000000000-1-1-2-5-2-2-4-2-2-5-7-12-8-11-9-14-14-20-14-24-26-24-65
000-1-1-11-1-1-2-3-3-7-7-3-23-4-12-13-25-28-15-37-51-28-61-62-83-119-88-105-97201
00000-10-10-1-2-1-5-20-200-10-11-20-20-3-29-39-18-46-47-62-104-64-78-72266
00000000000000000000000000000000
00000-10000003-39-9000000000000000-100
00000100-2-101010115515105914812212313293471
0000090-2-10104-21165261261219111525221329336-118
00000000000000000001124223000-1-1-19
00000000000000000000000000000000
001000001-1100001100813130-925-10225-41249-31118
-0.9-0.631.55-1.030.461.680.822.83.761.41.744.24-2.063.858.875.465.48.1522.5621.049.8717.6610.1334.1721.1145.6948.1849.1861.8354.3843.61-24.73
00000000000000000000000000000000

Neogen stock margins

The Neogen margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Neogen. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Neogen.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Neogen's sales revenue. A higher gross margin percentage indicates that the Neogen retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Neogen's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Neogen's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Neogen's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Neogen. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Neogen's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Neogen Margin History

Neogen Gross marginNeogen Profit marginNeogen EBIT marginNeogen Profit margin
2027e50.19 %14.9 %15.46 %
2026e50.19 %11.09 %13.13 %
2025e50.19 %8.54 %10.87 %
202450.19 %8.03 %-1.02 %
202349.37 %11.83 %-2.78 %
202246.09 %11.12 %9.16 %
202145.91 %15.84 %13 %
202046.94 %16.14 %14.23 %
201946.33 %16.44 %14.53 %
201846.82 %17.64 %15.86 %
201747.14 %18.11 %12.22 %
201647.65 %17.55 %11.39 %
201549.35 %18.76 %11.83 %
201449.56 %17.54 %11.4 %
201352.77 %19.61 %13.11 %
201250.22 %18.32 %12.23 %
201150.84 %20.73 %13.2 %
201051.96 %19.15 %12.46 %
200950.04 %17.27 %11.71 %
200851.95 %17.58 %11.82 %
200751.8 %15.68 %10.57 %
200651.1 %14.92 %9.67 %
200548.73 %11.94 %7.8 %

Neogen Stock Sales Revenue, EBIT, Earnings per Share

The Neogen earnings per share therefore indicates how much revenue Neogen has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Neogen earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Neogen's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Neogen’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Neogen's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Neogen Revenue, EBIT and net profit per share

DateNeogen Sales per ShareNeogen EBIT per shareNeogen Earnings per Share
2027e4.85 undefined0 undefined0.75 undefined
2026e4.62 undefined0 undefined0.61 undefined
2025e4.41 undefined0 undefined0.48 undefined
20244.27 undefined0.34 undefined-0.04 undefined
20234.35 undefined0.52 undefined-0.12 undefined
20224.88 undefined0.54 undefined0.45 undefined
20214.37 undefined0.69 undefined0.57 undefined
20203.96 undefined0.64 undefined0.56 undefined
20193.95 undefined0.65 undefined0.57 undefined
20183.81 undefined0.67 undefined0.6 undefined
20173.5 undefined0.63 undefined0.43 undefined
20163.18 undefined0.56 undefined0.36 undefined
20152.83 undefined0.53 undefined0.34 undefined
20142.49 undefined0.44 undefined0.28 undefined
20132.13 undefined0.42 undefined0.28 undefined
20121.91 undefined0.35 undefined0.23 undefined
20111.81 undefined0.38 undefined0.24 undefined
20101.52 undefined0.29 undefined0.19 undefined
20091.31 undefined0.23 undefined0.15 undefined
20081.14 undefined0.2 undefined0.13 undefined
20071.01 undefined0.16 undefined0.11 undefined
20060.95 undefined0.14 undefined0.09 undefined
20050.84 undefined0.1 undefined0.07 undefined

Neogen business model

Neogen Corp is a leading provider of food safety and animal health solutions based in Lansing, Michigan, USA. The company was founded in 1982 by James Herbert and initially focused on the development and manufacturing of rapid tests for the dairy industry. Since then, Neogen has become an internationally operating company with over 25 subsidiaries and 1,800 employees. Neogen's business model is based on providing solutions for safe and healthy food supply and animal husbandry. The company operates in two main divisions: Food Safety and Animal Safety. Within these divisions, Neogen offers a wide range of test kits, diagnostic tools, information management software, and other products that help minimize the risk of food poisoning and improve the health of livestock. In the Food Safety division, Neogen offers a variety of test kits that allow food producers and retailers to quickly and easily detect various types of contaminants in food. These include tests for salmonella, E. coli, listeria, and mycotoxins. The company also provides tools for monitoring water quality and verifying cleaning and disinfection processes in food processing plants. In the Animal Safety division, Neogen also offers an extensive range of diagnostic tools to improve the health of livestock. The tests include infectious diseases such as brucellosis, BSE (mad cow disease), mastitis, and leukemia. Additionally, Neogen provides tools for animal identification and animal health data management. Neogen has also specialized in the development of technologies to improve animal health and nutrition, such as probiotics and supplements for livestock. Another focus of Neogen is the development of information management software that enables food producers and retailers to streamline the process of food safety and quality. The software allows companies to track tests, analyze data, and implement best practices to minimize the risk of food poisoning. In recent years, Neogen has also increasingly focused on the global market, especially the Asian market. The company has subsidiaries in various parts of the world, including Europe, Latin America, and Asia. Neogen works closely with local regulatory authorities to offer its products in accordance with local requirements. In conclusion, Neogen Corp is a leading provider of food safety and animal health solutions, focusing on the development and manufacturing of test kits, diagnostic tools, and information management software. The company has experienced impressive growth in recent decades and is now operating internationally. With its commitment to safe and healthy food supply and animal husbandry, Neogen sets industry standards. Neogen is one of the most popular companies on Eulerpool.com.

Neogen SWOT Analysis

Strengths

Neogen Corp boasts several key strengths that contribute to its success in the market. Firstly, the company has a strong reputation for producing high-quality and innovative products. This reputation has been built through years of commitment to research and development, resulting in cutting-edge solutions for its customers.

Secondly, Neogen Corp has a diverse product portfolio, spanning multiple industries such as food safety, animal health, and genomics. This diversification mitigates risks associated with relying solely on one market segment and allows Neogen Corp to tap into various revenue streams.

Additionally, the company has a global presence, with operations in multiple countries. This international footprint provides Neogen Corp with access to a broader customer base and market opportunities worldwide.

Weaknesses

Despite its strengths, Neogen Corp also faces certain weaknesses that need to be addressed. One prominent weakness is its heavy dependence on key customers. If a major customer were to reduce its purchases or switch to a competitor, Neogen Corp could experience a significant decline in sales.

Furthermore, Neogen Corp has limited manufacturing capabilities, relying on third-party manufacturers for a portion of its products. This dependence on external vendors introduces potential risks and could impact product availability and quality control.

Opportunities

Neogen Corp can leverage various opportunities to drive growth and expand its market reach. For instance, increasing consumer demand for food safety solutions presents a chance for the company to introduce new products or enhance existing offerings. This trend aligns with Neogen Corp's expertise, giving it a competitive advantage.

Additionally, the growing adoption of genomics and molecular diagnostics provides Neogen Corp with an opportunity to further penetrate the healthcare industry. By investing in research and partnerships, the company can develop advanced genetic testing and diagnostic solutions to meet the evolving needs of the market.

Threats

Neogen Corp faces several threats that could impact its performance and market position. One significant threat is intense competition within its target markets. Competitors may launch similar products or offer competitive pricing, potentially eroding Neogen Corp's market share.

Additionally, regulatory changes and stricter industry standards pose a threat to Neogen Corp's operations. Compliance with evolving regulations requires continuous adaptation and investment in research and development, which may strain the company's resources.

Lastly, economic downturns and fluctuations in exchange rates can negatively affect Neogen Corp's financial performance, particularly in international markets where currency volatility is a concern.

Neogen Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Neogen Revenue by Segment

Segmente20222021202020192012
Product424.66 M USD376.3 M USD335.54 M USD339.44 M USD-
Service102.5 M USD92.16 M USD82.63 M USD74.75 M USD-

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Neogen Revenue by Segment

Segmente20222021202020192012
Natural Toxins Allergens and Drug Residues79.4 M USD76.61 M USD76.21 M USD78.37 M USD-
Rodenticides Insecticides and Disinfectants83.61 M USD77.46 M USD68.82 M USD66.39 M USD-
Genomics Services74.14 M USD67.02 M USD59.01 M USD51.94 M USD-
Culture Media And Other75.28 M USD56.92 M USD47.85 M USD49.86 M USD-
Veterinary Instruments and Disposables63.94 M USD48.13 M USD42.94 M USD44.58 M USD-
Bacterial and General Sanitation47.28 M USD44.01 M USD41.78 M USD41.97 M USD-
Animal Care and Other39.81 M USD35.9 M USD28.39 M USD29.94 M USD-
Life Sciences5.69 M USD5.72 M USD6.32 M USD7.86 M USD-

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Neogen Revenue by Segment

Segmente20222021202020192012
Product-----
Service-----

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Neogen Revenue by Segment

Segmente20222021202020192012
Food Safety259.98 M USD234.24 M USD212.69 M USD213.47 M USD91.1 M USD
Animal Safety267.18 M USD234.22 M USD205.48 M USD200.71 M USD92.94 M USD
Intersegment Elimination-----

Neogen Revenue by Region

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Neogen Revenue by Segment

DateForeign OperationsOther CountriesUnited States
2022-209.34 M USD317.82 M USD
2021-183.2 M USD285.26 M USD
2020-164.71 M USD253.46 M USD
2019-165.88 M USD248.3 M USD
201276.67 M USD--
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Neogen Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Neogen historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Neogen shares outstanding

The number of shares was Neogen in 2023 — This indicates how many shares 188.9 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Neogen earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Neogen's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Neogen’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Neogen's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Neogen stock splits

In Neogen's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Neogen.

Neogen latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.09 0.07  (-19.26 %)2025 Q1
6/30/20240.12 0.1  (-14.75 %)2024 Q4
3/31/20240.14 0.12  (-15.97 %)2024 Q3
12/31/20230.14 0.11  (-22.97 %)2024 Q2
9/30/20230.13 0.11  (-13.73 %)2024 Q1
6/30/2023-0.04 0.14  (492.16 %)2023 Q4
3/31/2023-0.02 0.12  (884.31 %)2023 Q3
12/31/20220.03 -0.19  (-720.92 %)2023 Q2
9/30/20220.14 0.05  (-64.99 %)2023 Q1
6/30/20220.12 0.14  (19.35 %)2022 Q4
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the Neogen stock

Eulerpool World ESG Rating (EESG©)

46/ 100

🌱 Environment

15

👫 Social

68

🏛️ Governance

54

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Neogen shareholders

%
Name
Stocks
Change
Date
10.23829 % BlackRock Institutional Trust Company, N.A.22,186,380124,4906/30/2024
9.02188 % The Vanguard Group, Inc.19,550,420-120,6456/30/2024
8.40117 % Norges Bank Investment Management (NBIM)18,205,34215,6686/30/2024
7.16679 % Select Equity Group, L.P.15,530,4392,914,8936/30/2024
5.54364 % William Blair Investment Management, LLC12,013,0724,717,6966/30/2024
5.34425 % Baillie Gifford & Co.11,580,986-208,5356/30/2024
4.01764 % Conestoga Capital Advisors, LLC8,706,2241,711,2389/30/2024
3.55119 % State Street Global Advisors (US)7,695,430135,0356/30/2024
3.43618 % Mackenzie Investments7,446,209-43,6846/30/2024
3.32490 % Baron Capital Management, Inc.7,205,048-99,9196/30/2024
1
2
3
4
5
...
10

Neogen Executives and Management Board

Mr. John Adent

(55)
Neogen President, Chief Executive Officer, Director (since 2017)
Compensation 5.33 M

Mr. David Naemura

(55)
Neogen Chief Financial Officer
Compensation 1.98 M

Mr. Doug Jones

(53)
Neogen Chief Operating Officer
Compensation 1.94 M

Dr. Amy Rocklin

Neogen Chief Legal & Compliance Officer
Compensation 1.46 M

Dr. Jason Lilly

(49)
Neogen Vice President, Americas, Australia and New Zealand
Compensation 822,806
1
2
3

Most common questions regarding Neogen

What values and corporate philosophy does Neogen represent?

Neogen Corp is a company that values innovation, integrity, and commitment to quality. Their corporate philosophy revolves around providing solutions for the food and animal safety industries through advanced technology and dedicated research. With a focus on developing and marketing products to ensure the safety of food, feed, and animal health, Neogen Corp aims to be a trusted partner for agricultural, veterinary, and food processing industries. By consistently delivering high-quality products and services, Neogen Corp reinforces its commitment to the safety and well-being of both humans and animals, making it a reputable player in the industry.

In which countries and regions is Neogen primarily present?

Neogen Corp is primarily present in several countries and regions around the world. These include the United States, Canada, Mexico, and various countries in Europe, such as Belgium, France, Germany, and the United Kingdom. Additionally, Neogen Corp has a strong presence in Asia, with operations in China and southeast Asian countries like Singapore. With its global reach, Neogen Corp continues to expand its presence and offer its innovative products and services to customers in diverse markets.

What significant milestones has the company Neogen achieved?

Neogen Corp has achieved several significant milestones throughout its history. The company successfully developed and introduced rapid food and animal safety tests, revolutionizing the industry. They expanded their product portfolio to include diagnostics for human healthcare, veterinary medicine, and agricultural concerns globally. Neogen Corp's continuous innovations in genomics, biosecurity, and animal safety further propelled its growth. The company established strategic partnerships and collaborations to enhance its product offerings and market reach. Neogen Corp's commitment to quality, accuracy, and reliability has earned them a strong reputation with customers worldwide. With a track record of achievements, Neogen Corp continues to lead as a trusted provider of innovative solutions in the field of food and animal safety.

What is the history and background of the company Neogen?

Neogen Corp, founded in 1982, is a leading global company specializing in food and animal safety solutions. Headquartered in Lansing, Michigan, Neogen is committed to developing innovative products for the agricultural, food, and pharmaceutical industries. With a diverse range of products and services, Neogen offers reliable and accurate diagnostic test kits, hygiene monitoring systems, and animal genomics solutions. They have built a solid reputation for their commitment to quality, customer service, and staying at the forefront of technological advancements. Neogen Corp's continuous dedication to improving food safety and animal health has made them a trusted and respected name in the industry.

Who are the main competitors of Neogen in the market?

The main competitors of Neogen Corp in the market include companies such as IDEXX Laboratories, Zoetis Inc., and Thermo Fisher Scientific Inc.

In which industries is Neogen primarily active?

Neogen Corp is primarily active in the food safety and animal health industries.

What is the business model of Neogen?

Neogen Corp is a leading company in the field of food and animal safety. Their business model revolves around providing diagnostic solutions and expertise to various industries. They offer a wide range of products and services including food safety testing, animal health products, and genomic testing. Neogen Corp utilizes advanced technologies and innovations to ensure the quality and safety of the food supply chain, prevent diseases in animals, and improve overall agricultural productivity. With a strong focus on research and development, Neogen Corp continuously delivers reliable and sustainable solutions to meet the evolving needs of their customers worldwide.

What is the P/E ratio of Neogen 2024?

The Neogen P/E ratio is -326.4.

What is the P/S ratio of Neogen 2024?

The Neogen P/S ratio is 3.33.

What is the Quality Investing of Neogen?

The Quality Investing for Neogen is 4/10.

What is the revenue of Neogen 2024?

The Neogen revenue is 924.22 M USD.

How high is the profit of Neogen 2024?

The Neogen profit is -9.42 M USD.

What is the business model of Neogen

The company Neogen Corp is a leading provider of food and animal health products. Its business model is focused on developing high-quality products and services that help improve food and animal health. The company is divided into two main areas: food and animal health. In the food sector, Neogen offers testing systems and diagnostic products that are used to monitor food safety and quality. Neogen's testing systems are used in food technology, animal feed control, and animal health. The products range from allergen-specific tests to detection methods for contamination or spoilage in food. In the animal health segment, the company offers a wide range of therapeutic and preventive products to promote animal health and performance. The product range includes products for the diagnosis and treatment of animals as well as medications, feed additives, and other products. Neogen Corp also offers services such as laboratory services and training. Neogen focuses on innovation and regularly invests in research and product development. The company works closely with leading universities and institutes to develop innovative products that meet the needs of customers. Product development focuses on creating effective solutions for animal health, preventing food contamination, and improving food quality. The company operates internationally and offers its products and services worldwide. Neogen has subsidiaries in Europe, Asia, and South America and works with distributors in over 60 countries. Neogen's global presence enables the company to meet the diverse needs of its customers in different countries and regions. In addition to its business activities, Neogen emphasizes its commitment to sustainability and social responsibility. The company is dedicated to promoting environmental and food quality, as well as the safety and health of animals. It also works to develop and improve its products and services to promote these goals. Neogen Corp is a leading provider of food and animal health products. The company offers a wide range of products and services aimed at improving food and animal health standards. The company relies on innovation and investments in research and development to create high-quality solutions for customers around the world. With a strong global presence and a commitment to sustainability and social responsibility, Neogen is well positioned to drive growth in these critical areas of the economy.

What is the Neogen dividend?

Neogen pays a dividend of 0 USD distributed over payouts per year.

How often does Neogen pay dividends?

The dividend cannot currently be calculated for Neogen or the company does not pay out a dividend.

What is the Neogen ISIN?

The ISIN of Neogen is US6404911066.

What is the Neogen WKN?

The WKN of Neogen is 883297.

What is the Neogen ticker?

The ticker of Neogen is NEOG.

How much dividend does Neogen pay?

Over the past 12 months, Neogen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Neogen is expected to pay a dividend of 0 USD.

What is the dividend yield of Neogen?

The current dividend yield of Neogen is .

When does Neogen pay dividends?

Neogen pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Neogen?

Neogen paid dividends every year for the past 0 years.

What is the dividend of Neogen?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Neogen located?

Neogen is assigned to the 'Health' sector.

Wann musste ich die Aktien von Neogen kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Neogen from 11/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/27/2024.

When did Neogen pay the last dividend?

The last dividend was paid out on 11/27/2024.

What was the dividend of Neogen in the year 2023?

In the year 2023, Neogen distributed 0 USD as dividends.

In which currency does Neogen pay out the dividend?

The dividends of Neogen are distributed in USD.

All fundamentals about Neogen

Our stock analysis for Neogen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neogen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.